Anthony Rodriguez

Anthony Rodriguez is a PhD candidate in bioengineering at the the University of Washington, and the president emeritus of the Student Engineering Business Association at UW. He is also co-founder of nPostBio.

Recent posts

No Time for the Academic Entrepreneur
The recurring question I hear from so many people in business is: “Why aren’t more startups generated by the university system?” It’s not an easy question, certainly not one to be... Read more »
It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool
It can be argued that among talent, cash and technology, no factor is more critical to a start up than talent. The talent drives innovation, attracts the venture capital and makes... Read more »
UW Business Plan Competition Kick-Starts Companies to Action
The University of Washington Business Plan Competition hosted by the Center for Innovation and Entrepreneurship (CIE) came to a close Thursday night, handing out $60,000 in prize money to an impressive... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Boston

Xcelerating Life Sciences Philadelphia

Anthony Rodriguez

Recent posts

No Time for the Academic Entrepreneur

It Takes a Village to Raise an Entrepreneur: Cultivating the Emerging Seattle Talent Pool

UW Business Plan Competition Kick-Starts Companies to Action

Underwriters and Partners

Potency Assay Development for Cell and Gene Therapy Products

How to Approach Life Sciences Fundraising

2019 Biopharma Outlook – Facing an Uncertain Future

Xconomy on Demand

We offer a number of ways to subscribe for free!